104 related articles for article (PubMed ID: 9561799)
1. Alpha 1-proteinase inhibitor is the serum regulator of the activity of p57, a C3-cleaving proteinase present in human erythrocyte membranes.
Rodrigues-Lima F; Hermann J; Jean D; Frade R
Biochim Biophys Acta; 1998 Mar; 1402(2):131-8. PubMed ID: 9561799
[TBL] [Abstract][Full Text] [Related]
2. Human erythrocyte ankyrin, a cytoskeleton component, generates the p57 membrane proteinase which cleaves C3, the third component of complement.
Hermann J; Barel M; Frade R
Biochem Biophys Res Commun; 1994 Oct; 204(2):453-60. PubMed ID: 7526850
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a monoclonal antibody against P57, the C3/C3b-cleaving proteinase expressed in human erythrocyte membranes.
Fiandino-Tirel A; Barel M; Lyamani F; Gauffre A; Hermann J; Frade R
Hybridoma; 1991 Aug; 10(4):449-58. PubMed ID: 1937496
[TBL] [Abstract][Full Text] [Related]
4. Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.
Jean D; Hermann J; Rodrigues-Lima F; Barel M; Balbo M; Frade R
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):961-9. PubMed ID: 8554545
[TBL] [Abstract][Full Text] [Related]
5. C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.
Ollert MW; Frade R; Fiandino A; Panneerselvam M; Petrella EC; Barel M; Pangburn MK; Bredehorst R; Vogel CW
J Immunol; 1990 May; 144(10):3862-7. PubMed ID: 2185316
[TBL] [Abstract][Full Text] [Related]
6. Identification of P-57, a serine proteinase, from human erythrocyte membranes, which cleaves both chains of human third component (C3) of complement.
Charriaut-Marlangue C; Barel M; Frade R
Biochem Biophys Res Commun; 1986 Nov; 140(3):1113-20. PubMed ID: 3535796
[TBL] [Abstract][Full Text] [Related]
7. Interaction between duodenase and alpha1-proteinase inhibitor.
Gladysheva IP; Popykina NA; Zamolodchikova TS; Larionova NI
Biochemistry (Mosc); 2001 Jun; 66(6):682-7. PubMed ID: 11421818
[TBL] [Abstract][Full Text] [Related]
8. Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells.
Frade R
Immunopharmacology; 1999 May; 42(1-3):39-45. PubMed ID: 10408364
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo.
Duranton J; Bieth JG
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):57-61. PubMed ID: 12600819
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
Forteza RM; Ahmed A; Lee T; Abraham WM
Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406
[TBL] [Abstract][Full Text] [Related]
12. Elastolysis by proteinase 3 and its inhibition by alpha(1)-proteinase inhibitor: a mechanism for the incomplete inhibition of ongoing elastolysis.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):356-61. PubMed ID: 11867344
[TBL] [Abstract][Full Text] [Related]
13. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
Duranton J; Adam C; Bieth JG
Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
[TBL] [Abstract][Full Text] [Related]
14. Chemoattractant activity of Staphylococcus aureus serine proteinase modified human plasma alpha-1-proteinase inhibitor.
Baran K; Górka M; Potempa J; Porwit-Bóbr Z
Antonie Van Leeuwenhoek; 1989 Nov; 56(4):361-5. PubMed ID: 2619289
[TBL] [Abstract][Full Text] [Related]
15. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
Nie J; Pei D
Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
[TBL] [Abstract][Full Text] [Related]
16. Some properties of the alkaline proteinase from Aspergillus melleus.
Luisetti M; Piccioni PD; Dyne K; Donnini M; Bulgheroni A; Pasturenzi L; Donnetta AM; Peona V
Int J Tissue React; 1991; 13(4):187-92. PubMed ID: 1821412
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S; Kohn D; Miller B; Gershon H
Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
[TBL] [Abstract][Full Text] [Related]
18. Purification and biochemical characterization of ovine alpha-1-proteinase inhibitor: mechanistic adaptations and role of Phe350 and Met356.
Gupta VK; Appu Rao AG; Gowda LR
Protein Expr Purif; 2008 Feb; 57(2):290-302. PubMed ID: 17997326
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
Reed SL; Keene WE; McKerrow JH; Gigli I
J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
[TBL] [Abstract][Full Text] [Related]
20. Functional diversification during evolution of the murine alpha(1)-proteinase inhibitor family: role of the hypervariable reactive center loop.
Barbour KW; Goodwin RL; Guillonneau F; Wang Y; Baumann H; Berger FG
Mol Biol Evol; 2002 May; 19(5):718-27. PubMed ID: 11961105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
